Champions Oncology (CSBR) Capital Expenditures Growth (5y) (2015 - 2026)
Powered by 
Analysis
Champions Oncology (CSBR) Capital Expenditures Growth (5y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | -32.72% |
| Apr 30, 2026 | -22.48% |
| Jan 31, 2026 | -50.16% |
| Oct 31, 2025 | -66.93% |
| Jul 31, 2025 | -16.81% |
| Apr 30, 2025 | -15.16% |
| Jan 31, 2025 | 14.33% |
| Oct 31, 2024 | 19.28% |
| Apr 30, 2024 | -15.11% |
| Jan 31, 2024 | -14.97% |
| Oct 31, 2023 | -22.08% |
| Jul 31, 2023 | 25.92% |
| Apr 30, 2023 | 29.09% |
| Jan 31, 2023 | 58.66% |
| Oct 31, 2022 | 79.96% |
| Jul 31, 2022 | -3.69% |
| Apr 30, 2022 | -2.86% |
| Jan 31, 2022 | 21.81% |
| Oct 31, 2021 | 112.70% |
| Jul 31, 2021 | 121.53% |